| UniProt ID | FGD3_HUMAN | |
|---|---|---|
| UniProt AC | Q5JSP0 | |
| Protein Name | FYVE, RhoGEF and PH domain-containing protein 3 | |
| Gene Name | FGD3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 725 | |
| Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton . | |
| Protein Description | Promotes the formation of filopodia. May activate CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. Plays a role in regulating the actin cytoskeleton and cell shape (By similarity).. | |
| Protein Sequence | MESGRGSSTPPGPIAALGMPDTGPGSSSLGKLQALPVGPRAHCGDPVSLAAAGDGSPDIGPTGELSGSLKIPNRDSGIDSPSSSVAGENFPCEEGLEAGPSPTVLGAHAEMALDSQVPKVTPQEEADSDVGEEPDSENTPQKADKDAGLAQHSGPQKLLHIAQELLHTEETYVKRLHLLDQVFCTRLTDAGIPPEVIMGIFSNISSIHRFHGQFLLPELKTRITEEWDTNPRLGDILQKLAPFLKMYGEYVKNFDRAVGLVSTWTQRSPLFKDVVHSIQKQEVCGNLTLQHHMLEPVQRVPRYELLLKDYLKRLPQDAPDRKDAERSLELISTAANHSNAAIRKVEKMHKLLEVYEQLGGEEDIVNPANELIKEGQIQKLSAKNGTPQDRHLFLFNSMILYCVPKLRLMGQKFSVREKMDISGLQVQDIVKPNTAHTFIITGRKRSLELQTRTEEEKKEWIQIIQATIEKHKQNSETFKAFGGAFSQDEDPSLSPDMPITSTSPVEPVVTTEGSSGAAGLEPRKLSSKTRRDKEKQSCKSCGETFNSITKRRHHCKLCGAVICGKCSEFKAENSRQSRVCRDCFLTQPVAPESTEKTPTADPQPSLLCGPLRLSESGETWSEVWAAIPMSDPQVLHLQGGSQDGRLPRTIPLPSCKLSVPDPEERLDSGHVWKLQWAKQSWYLSASSAELQQQWLETLSTAAHGDTAQDSPGALQLQVPMGAAAP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MESGRGSSTP -----CCCCCCCCCC | 32.27 | 26074081 | |
| 7 | Phosphorylation | -MESGRGSSTPPGPI -CCCCCCCCCCCCCC | 29.67 | 23401153 | |
| 8 | Phosphorylation | MESGRGSSTPPGPIA CCCCCCCCCCCCCCC | 48.00 | 30576142 | |
| 9 | Phosphorylation | ESGRGSSTPPGPIAA CCCCCCCCCCCCCCC | 34.89 | 28348404 | |
| 22 | Phosphorylation | AALGMPDTGPGSSSL CCCCCCCCCCCCCCC | 39.13 | 26074081 | |
| 26 | Phosphorylation | MPDTGPGSSSLGKLQ CCCCCCCCCCCCCEE | 21.64 | 26074081 | |
| 27 | Phosphorylation | PDTGPGSSSLGKLQA CCCCCCCCCCCCEEE | 35.18 | 26074081 | |
| 28 | Phosphorylation | DTGPGSSSLGKLQAL CCCCCCCCCCCEEEC | 42.72 | 26074081 | |
| 48 | Phosphorylation | AHCGDPVSLAAAGDG CCCCCCCHHHCCCCC | 20.06 | 26552605 | |
| 56 | Phosphorylation | LAAAGDGSPDIGPTG HHCCCCCCCCCCCCC | 24.92 | 23401153 | |
| 62 | Phosphorylation | GSPDIGPTGELSGSL CCCCCCCCCCCCCCE | 37.77 | 30108239 | |
| 66 | Phosphorylation | IGPTGELSGSLKIPN CCCCCCCCCCEECCC | 23.25 | 26552605 | |
| 68 | Phosphorylation | PTGELSGSLKIPNRD CCCCCCCCEECCCCC | 24.10 | 26552605 | |
| 76 | Phosphorylation | LKIPNRDSGIDSPSS EECCCCCCCCCCCCC | 34.12 | 26074081 | |
| 80 | Phosphorylation | NRDSGIDSPSSSVAG CCCCCCCCCCCCCCC | 25.43 | 26074081 | |
| 82 | Phosphorylation | DSGIDSPSSSVAGEN CCCCCCCCCCCCCCC | 38.92 | 26074081 | |
| 83 | Phosphorylation | SGIDSPSSSVAGENF CCCCCCCCCCCCCCC | 32.01 | 26074081 | |
| 84 | Phosphorylation | GIDSPSSSVAGENFP CCCCCCCCCCCCCCC | 21.96 | 30576142 | |
| 101 | Phosphorylation | EGLEAGPSPTVLGAH CCCCCCCCCCCCCHH | 32.08 | 26074081 | |
| 103 | Phosphorylation | LEAGPSPTVLGAHAE CCCCCCCCCCCHHHH | 32.47 | 26074081 | |
| 115 | Phosphorylation | HAEMALDSQVPKVTP HHHHHHHCCCCCCCC | 33.65 | 22468782 | |
| 121 | Phosphorylation | DSQVPKVTPQEEADS HCCCCCCCCHHHHCC | 25.94 | 30278072 | |
| 128 | Phosphorylation | TPQEEADSDVGEEPD CCHHHHCCCCCCCCC | 41.04 | 23401153 | |
| 136 | Phosphorylation | DVGEEPDSENTPQKA CCCCCCCCCCCCCHH | 43.38 | 30576142 | |
| 139 | Phosphorylation | EEPDSENTPQKADKD CCCCCCCCCCHHHHH | 24.05 | 28450419 | |
| 145 | Ubiquitination | NTPQKADKDAGLAQH CCCCHHHHHCCHHHH | 55.10 | - | |
| 157 | Ubiquitination | AQHSGPQKLLHIAQE HHHCHHHHHHHHHHH | 57.03 | - | |
| 174 | Ubiquitination | HTEETYVKRLHLLDQ CCCCHHHHHHHHHHH | 38.54 | - | |
| 220 | Ubiquitination | QFLLPELKTRITEEW CCCCHHHHHHCCCCC | 33.81 | - | |
| 220 | Ubiquitination | QFLLPELKTRITEEW CCCCHHHHHHCCCCC | 33.81 | - | |
| 239 | Ubiquitination | RLGDILQKLAPFLKM CHHHHHHHHHHHHHH | 43.07 | - | |
| 239 | Ubiquitination | RLGDILQKLAPFLKM CHHHHHHHHHHHHHH | 43.07 | - | |
| 308 | Ubiquitination | PRYELLLKDYLKRLP CHHHHHHHHHHHCCC | 44.27 | - | |
| 308 | Ubiquitination | PRYELLLKDYLKRLP CHHHHHHHHHHHCCC | 44.27 | - | |
| 327 | Phosphorylation | DRKDAERSLELISTA CHHHHHHHHHHHHHH | 20.08 | 24247654 | |
| 355 | Phosphorylation | MHKLLEVYEQLGGEE HHHHHHHHHHHCCCC | 6.65 | 23879269 | |
| 379 | Ubiquitination | IKEGQIQKLSAKNGT HHHCCHHHHHHCCCC | 46.14 | - | |
| 379 | Ubiquitination | IKEGQIQKLSAKNGT HHHCCHHHHHHCCCC | 46.14 | - | |
| 397 | Phosphorylation | RHLFLFNSMILYCVP CHHHHHHHHHHHHHH | 10.40 | 19835603 | |
| 401 | Phosphorylation | LFNSMILYCVPKLRL HHHHHHHHHHHHHHH | 4.77 | 19835603 | |
| 412 | Ubiquitination | KLRLMGQKFSVREKM HHHHCCCCCCCHHCC | 33.60 | - | |
| 414 | Phosphorylation | RLMGQKFSVREKMDI HHCCCCCCCHHCCCC | 27.57 | - | |
| 446 | Phosphorylation | IITGRKRSLELQTRT EEECCCCEEECCCCC | 29.27 | 28857561 | |
| 486 | Phosphorylation | KAFGGAFSQDEDPSL HHHCCCCCCCCCCCC | 35.87 | 29802988 | |
| 492 | Phosphorylation | FSQDEDPSLSPDMPI CCCCCCCCCCCCCCC | 54.52 | 28348404 | |
| 494 | Phosphorylation | QDEDPSLSPDMPITS CCCCCCCCCCCCCCC | 24.16 | 28348404 | |
| 500 | Phosphorylation | LSPDMPITSTSPVEP CCCCCCCCCCCCCCC | 21.78 | 26074081 | |
| 501 | Phosphorylation | SPDMPITSTSPVEPV CCCCCCCCCCCCCCE | 27.84 | 26074081 | |
| 502 | Phosphorylation | PDMPITSTSPVEPVV CCCCCCCCCCCCCEE | 28.53 | 26074081 | |
| 503 | Phosphorylation | DMPITSTSPVEPVVT CCCCCCCCCCCCEEE | 27.07 | 26074081 | |
| 510 | Phosphorylation | SPVEPVVTTEGSSGA CCCCCEEECCCCCCC | 21.26 | 26074081 | |
| 511 | Phosphorylation | PVEPVVTTEGSSGAA CCCCEEECCCCCCCC | 27.09 | 26074081 | |
| 514 | Phosphorylation | PVVTTEGSSGAAGLE CEEECCCCCCCCCCC | 21.26 | 26074081 | |
| 515 | Phosphorylation | VVTTEGSSGAAGLEP EEECCCCCCCCCCCH | 43.22 | 26074081 | |
| 526 | Phosphorylation | GLEPRKLSSKTRRDK CCCHHCCCCCCCCHH | 32.59 | 26074081 | |
| 527 | Phosphorylation | LEPRKLSSKTRRDKE CCHHCCCCCCCCHHH | 48.78 | 26074081 | |
| 529 | Phosphorylation | PRKLSSKTRRDKEKQ HHCCCCCCCCHHHHH | 32.65 | 26074081 | |
| 533 | Acetylation | SSKTRRDKEKQSCKS CCCCCCHHHHHHHHH | 66.07 | 20167786 | |
| 540 | Phosphorylation | KEKQSCKSCGETFNS HHHHHHHHHHHHHHH | 31.51 | 26552605 | |
| 544 | Phosphorylation | SCKSCGETFNSITKR HHHHHHHHHHHHHHC | 17.25 | 30108239 | |
| 547 | Phosphorylation | SCGETFNSITKRRHH HHHHHHHHHHHCHHH | 27.69 | 30576142 | |
| 549 | Phosphorylation | GETFNSITKRRHHCK HHHHHHHHHCHHHHC | 20.51 | 27794612 | |
| 550 | Acetylation | ETFNSITKRRHHCKL HHHHHHHHCHHHHCC | 45.85 | 20167786 | |
| 586 | Phosphorylation | VCRDCFLTQPVAPES CCHHHCCCCCCCCCC | 15.58 | 24114839 | |
| 593 | Phosphorylation | TQPVAPESTEKTPTA CCCCCCCCCCCCCCC | 40.58 | 23312004 | |
| 594 | Phosphorylation | QPVAPESTEKTPTAD CCCCCCCCCCCCCCC | 39.58 | 23312004 | |
| 597 | Phosphorylation | APESTEKTPTADPQP CCCCCCCCCCCCCCC | 21.46 | 26552605 | |
| 599 | Phosphorylation | ESTEKTPTADPQPSL CCCCCCCCCCCCCCE | 49.26 | 23312004 | |
| 605 | Phosphorylation | PTADPQPSLLCGPLR CCCCCCCCEEEEEEE | 28.82 | 23312004 | |
| 656 | Ubiquitination | TIPLPSCKLSVPDPE CCCCCCCEEECCCHH | 48.40 | - | |
| 658 | Phosphorylation | PLPSCKLSVPDPEER CCCCCEEECCCHHHH | 19.66 | 22617229 | |
| 673 | Ubiquitination | LDSGHVWKLQWAKQS CCCCCEEEEHHHHHH | 29.70 | - | |
| 710 | Phosphorylation | HGDTAQDSPGALQLQ CCCCCCCCCCCEEEE | 17.10 | 26074081 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FGD3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FGD3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of FGD3_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-9 AND SER-128, AND MASSSPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128, AND MASSSPECTROMETRY. | |